Market Cap

Enzymatica AB Market Capitalization:

kr430.0 Million

SEK as of July 1, 2024

US$40.5 Million

business Enzymatica AB Company Profile

Enzymatica AB Main Stock Listing

OMX: ENZY

Market Capitalization History of Enzymatica AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Enzymatica AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr648.0 M -12.24%
Jan. 1, 2023 kr738.3 M -13.29%
Jan. 1, 2022 kr851.5 M -72.76%
Jan. 1, 2021 kr3.13 B 275.00%
Jan. 1, 2020 kr833.5 M 120.87%
Jan. 1, 2019 kr377.4 M -50.57%
Jan. 1, 2018 kr763.4 M 54.69%
Jan. 1, 2017 kr493.5 M -4.02%
Jan. 1, 2016 kr514.2 M -69.92%
Jan. 1, 2015 kr1.71 B -35.87%
Jan. 1, 2014 kr2.67 B -10.68%
Jan. 1, 2013 kr2.98 B 202.94%
Jan. 1, 2012 kr984.9 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Enzymatica AB Categories

Sweden languages Healthcare languages Drug Manufacturers—Specialty & Generic
Sweden Healthcare Sweden Drug Manufacturers—Specialty & Generic

Stocks & Indices

Enzymatica AB has the following listings and related stock indices.


Stock: OMX: ENZY

Stock: FSX: EN9

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.